Australia’s AI workforce revolution: automation paves the way for a four-day work week.

In Short

UiPath’s report highlights the rapid shift towards “agentic automation,” where AI makes autonomous decisions, encouraging businesses to reassess roles and harness automation for productivity. This evolution may enable a four-day work week and necessitates the retraining of staff while ensuring regulations are in place for trust and compliance with AI integration.

The trend towards work reallocation is rapidly advancing, with UiPath’s new report identifying significant shifts in AI and automation.

Key insights from the report suggest a move towards “agentic automation,” where AI begins to make autonomous decisions. Yelena Galstian, Head of Solutions and Customer Advisory at UiPath shares her key insights.

Organisations are encouraged to reassess existing roles and identify areas where automation can enhance productivity.

A critical aspect will be the orchestration of collaboration between human employees, AI agents, and software robots to ensure effective teamwork.

Looking ahead, the motto for businesses is to “redesign and reassign” processes while considering how AI can handle repetitive tasks, allowing human employees to focus on more complex responsibilities.

As organisations embrace these changes, we could see a potential transition to a four-day work week, made feasible through increased efficiency and productivity from AI.

For further insights into the research and methodologies for implementing AI in business, interested parties can connect with the UiPath team through their website.

AI is transforming supply chains: enhancing efficiency, demand forecasting, delivery optimisation through advanced technologies.

Supply chain issues continue to challenge industries worldwide.

AI is increasingly seen as a solution to enhance efficiency and resilience within this sector.

To understand its impact, Jyot Singh, CEO of RTS Labs, joined to share his insights.

By utilising historical data, algorithms can predict future demand, facilitating better inventory management.

Additionally, advances in generative AI further enhance these forecasts by incorporating sentiment analysis and other factors.

AI also optimises delivery routes by analysing real-time data on traffic and weather conditions, thus reducing costs.

Companies, such as UPS, utilise technologies to streamline last-mile delivery, which is the most expensive portion of the supply chain.

AI’s role extends to improving vendor management and procurement efficiency through smart contracts and data-driven decision-making.

This helps businesses assess vendor reliability and make informed choices about allocating resources effectively.

Moreover, the digital twin technology allows businesses to simulate their supply chains virtually, testing various scenarios to identify potential disruptions.

American technological research and consulting firm Gartner predicts that by 2026, 60% of global supply chains will adopt digital twin applications, enhancing their ability to manage complex logistics.

Pioneering AI in cancer drug discovery with novel therapeutics and expansion plans for 2025.

Alan Roth, the Chief Executive Officer at Oxford Drug Design, highlighted the urgent need for innovative cancer therapies, stating that while progress has been made in oncology, much work remains.

The company aims to develop first-in-class therapies to address significant unmet needs in cancer treatment.

Their advanced AI discovery platform was developed from foundational research at the University of Oxford, which has significantly improved over the years.

Currently, Oxford Drug Design is actively running five therapeutic programs targeting cancer and other diseases, introducing novel mechanisms and molecules.

AI plays a crucial role in designing precise molecules for biological targets, making it an essential component of the drug discovery process.

For more information on their technology and potential investment opportunities, visit Oxford Drug Designs offical website.